AI MARKET SCANNING

Tvardi Therapeutics Inc

📅 Next Catalyst: Nov 12, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP +0.29%
MAX GAP RECORD -4.41%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $TVRD
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 12, 2026 Earnings Release 2026-11-12 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 14, 2026 Earnings Release 2026-08-14 (BEFORE OPEN)
+2.26%
May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE)
+0.95%
Nov 13, 2025 Earnings Release 2025-11-13 (AFTER CLOSE)
-0.73%
Aug 14, 2025 Earnings Release 2025-08-14 (AFTER CLOSE)
+3.36%
May 13, 2025 Earnings Release 2025-05-13 (AFTER CLOSE)
-4.41%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.3%
Bullish Gaps (2)
Bearish Gaps (1)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $TVRD

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗